NCT01683292View on ClinicalTrials.gov

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

May 31, 2007

Conditions
Parkinson's Disease
Interventions
DRUG

Inhaled VR040

DRUG

Placebo for VR040

Placebo arm

Trial Locations (1)

G51 4TF

Southern General Hospital, Glasgow

All Listed Sponsors
collaborator

Vectura Limited

INDUSTRY

lead

South Glasgow University Hospitals NHS Trust

OTHER

NCT01683292 - Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease | Biotech Hunter | Biotech Hunter